Phospho-Chk1 (Ser345) Polyclonal antibody 28803-1-AP proteintech

$149.00
In stock
SKU
28803-1-AP
Catalog No.SizePrice (USD)
28803-1-AP-20UL20 μL$149.00
28803-1-AP-100UL100 μL$449.00
Catalog Number28803-1-AP
SynonymsCHEK1, CHK1, CHK1 checkpoint homolog, Chk 1, CHEK 1
HostRabbit
Reactivityhuman, mouse
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IF/ICC, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inCalyculin A treated NIH/3T3 cells, Calyculin A treated HeLa cells
Tested Applications — Positive IF/ICC detected inCalyculin A treated HeLa cells
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:2000
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Positive WB detected inCalyculin A treated NIH/3T3 cells, Calyculin A treated HeLa cells
Positive IF/ICC detected inCalyculin A treated HeLa cells
Western Blot (WB)WB : 1:500-1:2000
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Tested Reactivityhuman, mouse
Cited Reactivityhuman, mouse
ClassPolyclonal
TypeAntibody
ImmunogenPeptide Predict reactive species
Full NameCHK1 checkpoint homolog (S. pombe)
Calculated Molecular Weight54 kDa
Observed Molecular Weight50 kDa
GenBank Accession NumberBC004202
Gene SymbolChk1
Gene ID (NCBI)1111
RRIDAB_2918206
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDO14757
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for Phospho-Chk1 (Ser345) antibody 28803-1-APDownload protocol
WB protocol for Phospho-Chk1 (Ser345) antibody 28803-1-APDownload protocol
humanWB Cell Biol Int RPL27 Promotes Gastric Cancer Progression by Enhancing Oxidative Phosphorylation Via FMC1. Authors - Yan Zheng View Article
human, mouseWB Drug Resist Updat RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling. Authors - Baichuan Zhou View Article
Arnaud (Verified Customer) (08-04-2026)Some aspecific bands at the same size Applications: Western Blot Primary Antibody Dilution: 1:1000 for WB Cell Tissue Type: HeLa
Citations12
DilutionsWB : 1:500-1:2000 IF/ICC : 1:200-1:800
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

The checkpoint kinase 1 (Chk1) is a conserved kinase that imposes cell cycle delays in response to impediments to DNA replication. Chk1 kinase is downstream of the ATR kinase. ATR phosphorylates Chk1 kinase and other proteins to ensure replication is being blocked as to avoid replication fork collapse and DNA damage. Activation of Chk1 involves phosphorylation at Ser317 and Ser345 by ATM/ATR, followed by autophosphorylation of Ser296. In vitro Chk1 binds to and phosphorylate the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C, which control cell cycle transitions by dephosphorylating cyclin-dependent kinases. (PMID:22941630, PMID: 32571801, PMID:19276361) Protocols Product Specific Protocols IF protocol for Phospho-Chk1 (Ser345) antibody 28803-1-AP Download protocol WB protocol for Phospho-Chk1 (Ser345) antibody 28803-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. XunZi, an AI biologist, reveals disease-modifying targets
    Journal: Nat Biomed Eng | Authors: Xinhe Huang | Species: human | Application: WB
  2. The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin
    Journal: Transl Oncol | Authors: Haochen Su | Species: human | Application: WB
  3. JMJD5 promotes chemotherapy sensitivity of cisplatin in NSCLC by enhancing DNA damage.
    Journal: Biochem Biophys Res Commun | Authors: Jing He
  4. CCPG1-mediated reticulophagy promotes tumorigenesis and cisplatin resistance in bladder cancer.
    Journal: Autophagy | Authors: Yang Dong | Species: human | Application: WB
  5. RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling.
    Journal: Drug Resist Updat | Authors: Baichuan Zhou | Species: human, mouse | Application: WB
  6. RPL27 Promotes Gastric Cancer Progression by Enhancing Oxidative Phosphorylation Via FMC1.
    Journal: Cell Biol Int | Authors: Yan Zheng | Species: human | Application: WB
  7. BLM as a potential therapeutic target in cutaneous malignant melanoma.
    Journal: Biochem Pharmacol | Authors: Lidan Zhang | Species: human | Application: WB
  8. Structurally diverse tetrahydroxanthone analogues from Paraconiothyrium sp. AC31 with pyroptosis induction through targeted inhibition of PARP1 in hepatocellular carcinoma cells
    Journal: Bioorg Chem | Authors: Meng-Ke Zhang | Species: human | Application: WB
  9. P2RY6 deletion promotes UVB-induced skin carcinogenesis by activating the PI3K/AKT signal pathway
    Journal: Cancer Sci | Authors: Peng Xu | Species: human | Application: WB
  10. The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin
    Journal: Transl Oncol | Authors: Haochen Su | Species: human | Application: WB
  11. RPL27 Promotes Gastric Cancer Progression by Enhancing Oxidative Phosphorylation Via FMC1.
    Journal: Cell Biol Int | Authors: Yan Zheng | Species: human | Application: WB
  12. JMJD5 promotes chemotherapy sensitivity of cisplatin in NSCLC by enhancing DNA damage.
    Journal: Biochem Biophys Res Commun | Authors: Jing He
  13. Radiation-induced atrial fibrillation is driven by cellular senescence via the GATA4 - NF-κB pathway and rescued by D/Q senolytic therapy.
    Journal: Int Immunopharmacol | Authors: Chao Zhang | Species: mouse | Application: WB

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:Phospho-Chk1 (Ser345) Polyclonal antibody 28803-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.